Cancer - Introduction to Eclectic Oncology
(C) 2010 by John W. Apsley, II, MD(E), ND, DC - www.doctorapsley.com
{{{Pardon our mess - under construction}}}
“Dissolving tumors (tumorlysis) has never been difficult for those highly skilled in the practice of Eclectic Medicine. Accomplishing this at a well tolerated pace while comprehensively re-establishing the fixity of the patient’s cellular milieu is the core objective. Clinically, the only means to this core objective is through The Regeneration Effect. Once The Regeneration Effect is established in the patient, all cancer dissolves and does not return. Such a methodology best defines the Art & Science of Eclectic Oncology.”
John W. Apsley, II, MD(E), ND, DC
Worldwide, cancer is diagnosed in approximately 11 million people every year and is responsible for almost 8 million deaths. W.H.O. expects this rate to double by 2020.[Click Here to View Report]
An ad hoc reviewer for the National Cancer Institute, the National Science Foundation and the Department of Veterans Affairs, Dr. Guy B. Faguet, in his book The War on Cancer: Anatomy of Failure A Blueprint for the Future, concludes that reports of offical cancer statistics can be misleading. He writes:
"Given the enormous impact of lung cancer on overal cancer statistics, statisticians and epidemiologists attempt to uncover underlying trends among cancers by analyzing incidence and mortality data after excluding lung cancer. After excluding lung cancer, the overall cancer incidence between 1950 and 2000 rose 1.5% per year, but mortality declined 0.4% per year [see Table IV]. However, a detailed analysis of mortality trends is more sobering. Indeed, as shown in the figure, of the 28 most frequent cancers in the US, 10 experienced a yearly drop in mortality of 1% or greater, but 6 saw their mortality increase by more than 1% a year. The latter accounted for 345,568 deaths in 2000 compared to 101,785 for the former, a ratio of over 3:1. Even after exclusion of lung cancer deaths in 2000 (155,788), the ratio remains nearly 2:1, which is to say that between 1950 and 2000 twice as many Americans died of cancers with increasing rather than with decreasing mortality rates. Furthermore, improvements in cancer mortality for 4 of 7 cancers declining by over 2% per year since 1950 (stomach cancer in both sexes, and in gynecologic and colorectal cancers in women) are attributable to:
the introduction of food refrigeration, to
improved dietary and sanitary habits,
to early detection, and to
better supportive medical care,
rather than to improved cancer therapy...
... Indeed, factors other than therapy affect survival favorably. They include improvements in supportive medical care and better screening and diagnostic tools. The latter two enable detection of more cases in the curable and non-curable earlier stages of the disease. Because their cancer was diagnosed earlier in its course, these patients will survive longer (called "lead-time bias") than individuals with more advanced disease diagnosed in the past independently of their treatment."[1]
(Bold, Italics and Underline mine)
Albert Einstein once said - "The right to search for truth implies also a duty; one must not conceal any part of what one has recognized to be true."
On this note, Derva Davis, veteran to the National Academy of Sciences (NAS) and the founding director of the Board on Environmental Studies and Toxicology at NAS, as well as Scholar in Residence at the NAS, tells a very interesting story in her recent book, The Secret History of the War on Cancer, which relates to Einstein's above admonition:

"It's taken me twenty years to write this book. My first try ended in 1986 after I explained to Frank Press, my boss at the National Academy of Sciences, that I had been offered a hefty advance to write about the fundamental misdirections of the war on cancer. With support from Press, the National Institute of Environmental Health Sciences, and universities and research institutions in Europe and the United States, my colleagues and I had published a series of papers showing that cancer had actually increased and it couldn't all be explained by smoking, improved diagnoses or aging. Judged by this standard, the then two-decades-long war on cancer wasn't going well...
Press, an MIT professor and former science adviser to President Jimmy Carter, was a seasoned diplomat and not a person I would ever play poker with, even if I knew how. He nodded as I told him of my plans (to write a book detailing why the war on cancer wasn't going well) and then said gravely, 'It had better be a good book.'
I replied, 'I guess they think it will be. They're offering me more than half my annual salary. That's quite a lot for a first-time author.'
'It had better be a really, really good book,' he said.
I didn't understand. 'Of course they expect it to be good,' I said. 'So do I.'
'Well,' he explained, 'it had better be, because you won't be able to work here after you write it.'
Davis continues by describing the modus operandi of the conventional cancer establishment:
"...I watched the maturing of the science of doubt promotion - the concerted and well-funded effort to identify, magnify and exaggerate doubts about what we could say that we know as a way of delaying actions to change the way the world operates... How did we get to this point? Since its formal launch more than thirty-five years ago, the war on cancer has been fighting many of the wrong battles with the wrong weapons and the wrong leaders... My goal in this book is to explain when, how, why and by whom the spotlight has been kept away from many of the things that produce cancer. I will show how two radically different sets of standards have been applied to learning how to treat the disease on the one hand, and figuring out what produces it on the other. Where animal studies on the causes of cancer exist, they are often faulted as not relevant to humans. Yet when studies of almost identical design are employed to craft novel treatments and therapies, the physiological differences between animals and humans suddenly become insignificant."[2]
(Bold, Italics and Parenthesis mine)
What Are the Causal, Regeneration Effects for Cancer?
There are always key reasons why people get cancer (it's all about the milieu or "turf"). Although it is true that 80% to 90% of the cancer cases are intimately associated with toxins in our environment,[3] the principle of Bernard's Strict Determinism rules the day [see here]. To this end, Eclectic Oncology looks to restoring the natural healing powers of the human body, initiated by detoxifying out the enironmental toxins. There are a strict set of rules that apply to this method:
Ø The first and foremost is to optimally resaturate the body with oxygen.[4], [5]
Ø The second is to optimally resaturate the body with unique forms of structured (3D-organized molecule-by-molecule) water,
which I call structured alkaline water or SAW.[6], [7]
Ø The third is to optimally resaturate the average human body's 75 trillion cells with unique, colloidal minerals, especially
potassium, magnesium, manganese, zinc, copper, iodine and rubidium.[8], [9]
Ø The fourth is to immediately screen for and correct frank or unsuspected low thyroid function.[10], [11]
Ø The fifth is to eradicate infectious loads.(A), (B), (C), [12]
Ø The sixth is to correct all digestive function.[11], [13]
Ø The seventh is to correct the body's pH gradient (hyperacidity).[14], [15]
Ø The eighth is to thoroughly detoxify the congested liver, which in cancer patients typically arises from: (1) low thyroid function,
(2) low fiber diets and (3) disturbed intestinal flora (low populations of good probiotics like acidophilus).[11]
Ø The nineth is to invigorate the patient's lifestyle with a diet rich in raw food factors, eliminating exposure to any and all toxins,
restore fitness, address addictive behaviors and change occupations that harm one's self, those around us, or our planet in general.
[3], [16], [17], [18], [19], [20]
Ø The tenth is to instruct each patient how to practice mind-over-matter techniques (including prayer and meditation) that eradicate harmful mental conditioning
such as:[21], [22], [23], [24]
ü Unresolved emotional shocks and constellations involving oneself, one's family, and those closest to mind and/or heart;
ü Negative or unproductive attitudes towards oneself, one's family, and the Universe in general;
ü Lack of discipline;
ü Deficiency of loving, calming and charitable practices; and possibly
ü Unhealthy compulsive or abusive behaviors.
The key to overcoming all chronic degenerative diseases is to always restore the body's self-healing system first. Why? Because it repairs at rates of speed many orders of magnitude greater than any other known extrinsic system of healing - {Link Here}.
Then the "footing" of all other natural healing tools employed will have the advantage of driving forward from the high-ground. The high-ground regains us the high-energy milieu or ideal turf absolutely essential for disease-free living.
This is the perfect example of a true causal approach to health and disease. For further information - {Click Here}.
What Is Cancer?
The turf of Cancer is one of cellular depravity and regional chaos.
In a very real biological sense, it is cellular mindlessness.
Specifically, the cell to cell communications are all nonsensical, garbled, and muted. This leads to bizarre adaptation of the cells into forms which function the best they can in this chaotic turf while starving for energy. Thus, their internal programs, deprived of outside references to indicate otherwise, kick into a "survival at all costs" mode and to hell with protocol! There can be no finer example of the low-ground/low-gain milieu than the mindless, chaotic turf of cancer.[5], [7], [25], [26]
Just like a placenta in tow with its embryo finding themselves in an 'in utero' barren wasteland, the cells spare no effort to improvise, and in the process go rogue.
This turf has four components which play out just as a musical string quartet would perform the Overture to Dante's Divine Comedy - "The Inferno." A Cello and a Double Bass lay-out the topography and climate of the turf, while one Violin and one Viola drive the two speeds of the turf's operations. The four instruments conspire in their play to inspire enough chaos in notes that cannibalism is the only thing that can thrive.
The Violin & Viola
The turf thrives simultaneously in both slow and fast motion. The Violin performs the faster pace, while the Viola sings the slower.
Ø From a harmonic perspective the Viola backs up the Violin.
Ø Visually, just as in Dante's Divine Comedy, the Viola sings as if it were the beast Cerebrus which guards over an imprisoned hoard of lost souls.
Ø Visually, just as in Dante's Divine Comedy, the Violin performs as the entire choir of lost souls.
Ø From a biological viewpoint, the Viola behaves as if it were a rogue placenta, protecting and feeding a rogue embryo. Ø From a biological viewpoint, the Violin performs as if it were a rogue embryo, deformed and insatiable, totally dependent upon its alliance to a rogue placenta.
In review - the metabolism of the rogue placenta is slow, cannibalistic and holds captive the cells of the rogue embryo. The rogue embryo feeds the offerings from the rogue placenta, in a perfect symbiosis (one helps the other to survive), in a turf which is desolate and without sustanance - the Wrath of Hell. The two produce nothing that cannot be recycled to grow and support more cancer cells, while at the same time their musical chords intoxicate the surrounding normal healthy cells. Twenty-four/seven, emergency rationing plus extreme efficiency rules the day, which gains a significant competitive advantage over the means normal cells must employ to survive.[27]
Enter - The Cello & Double Bass
And now things get interesting as the two respective rogue cells accelerate and brake as if dualing race cars (that is, cells that grow, consume, divide and die much more rapidly than adjacent normal cells). Make no mistake about it, the cancer cells "know" that it is a race to the death with all competitors. Their objective is strictly about sucking up all available supplies before all others.[28] Their purpose is mindless. So in this light, cancer's turf confers great danger to the host. It also explains why most folks with cancer do not die from the cancer itself, rather from terminal malnutrition caused by this free-for-all.[29]
Clever as can be, the quartet of cancer stirs up the turf to favor their survival and none other. So the purpose of the Cello and Double is to excite extremes in the turf's weather - either hot and stormy, or cold and icy.
Ø From a harmonic p erspective, the Cello emits signals that climate change the turf to hot steamy rain, while the Double Bass emits signals that chill and ice up the turf.
Ø From a biological viewpoint, the Cello is akin to an immune system with its throttle turned all the way up into highest gear,[30] while the Double Bass is akin to an immune system throttled downturned into lowest gear - or worse - into reverse.[31]
Once the Cello places the immune system into high gear, it redlines and starts over secreting destructive inflammatory agents. These rogue agents simply "riot" along the turf as free-radicals. On the other hand, the Double Bass) emits signals that literally "paralyze" life-saving immune cells. This enables microbe invasion into cancer's turf, such as Candida, which then contributes and amplifies the inflammation.[32]
In a classic chicken verses the egg paradox, it becomes challenging to determine if infestations of microbes arrived second or first on the scene? Did insidious microbe populations first gain some footing, and then terra-formed the turf into a perfect haven for future cancer growth? Or was it cancer cells that first arrived and tweaked the turf into a pefect haven for exploding microbe populations? The answer to this riddle may surprise many.
Neither microbes nor cancer cells created the turf to cancer!
The turf was first created by the eight causal factors listed above under Claude Bernard's principle of Strict Determinism. In other words, if the turf had remained steadfast and rich in the above eight factors, the growth of cancer and microbes would have been properly preventedmanaged by the body's defenses. And beyond this, what is vital for everyone to understand is that both microbes and rogue cells now muck up the turf even more, making a perfect self-perpetuating storm. As the perfect storm over this race for life & death is fueled by the bow slicing the strings of the quartet, sparks begin to fly igniting Molotov cocktails which thoroughly inflame turf.[33], [34] It can therefore be argued that the turf of cancer is indeed the turf of infesting microbes, and the turf of infesting microbes is indeed the turf of cancer.(A), (B), (C), [12]

The Molotov cocktails appear to be powerful facilitators to the growth and replication rate of both cancer cells as well as invading microbes.[35], [36]. The Molotov cocktails both burn and scar the turf, rampaging in hiccups of metabolic flame-up and flame-out. When combined, these race cars already driving haphazardly become turbo-charged. At such extremes in both speed and weather, the aftermath only add more cells to the inflamed carnage.
In summary, the quartet of cancer and co-arising infections cloak themselves from immune cells and amplify immune cell paralysis.[37] Specifically: The quartet builds an impenetrable hypoxic & hyperacidic moat around itself. As the moat engorges surrounding healthy cells, they can go pleomorphic and either die or convert to cancer cells themselves.[38] Second, in times of famine (low blood & fuel supply), the quartet of cancer undergoes strategic suicide (called necrosis).[39] Necrosis, which spurs cannibalism, is one sequence in which cancer recycles itself (termed autophagy).
Cancer is highly efficient at autophagy, and the conditions common to cancer profoundly delay the programmed death of cancer cells. This combination give cancer cells great competitive advantage over the adjacent normal cells.
Co-infection may undergo a feeding frenzy and even mimic cancer itself.[39] Third, as the surrounding normal cells die, their cell parts enter into the quartet's ability to efficiently cannibalize them. Indeed, the quartet of cancer is the most perfected, cannabalistic graverobber of all time. And all along the way, inflammatory Molokov cocktails rule the turf. In this horrific manner, the Overture to Danate's Inferno sings on and on in the bowels of Hell.[40] Now it is time to take a closer look at how this relates to conquering cancer,
since knowing one's enemy is the first step to defeating one's enemy.
By knowing the enemy, its strengths and weaknesses can be identified. Then, its Achilles' Heel may be determined. With this in mind, consider:
Ø The high speed production of dead cancer cells is termed necrosis.
Ø The Molotov cocktails are the highly inflamed battle clashes between rogue cells, infectious critters and the semi-paralyzed immune cells.
Ø As the Cellos play, they emit scorching third-degree burns intensifying more rogue growth (via pro-inflammatory cytokines and free-radicals).
Ø The high-speed production of newly hatched voracious cancer cells have seemingly become invincible due to a loss of healthy "programmed cell death" termed apoptosis.
Ø This entire turf is forever kept in play by a never ending supply of replacement parts from all the dead and dying normal and abnormal cells, enabling repair under virtually any contingency.
Ø The endless supplies from such a barren wasteland come from nothing less than true cannibalism termed autophagy. Autophagy is the perfect lean, mean efficiency machine, and originates from the surviving race car drivers harnessed to the first kind of engine (the Viola). This race car has all the equipment and technology on board to scoop up all the debris on the speedway as it careens down the track. What results are cannibalized recycled parts and still combustible smog that support the other three string instruments of the quartet. Autophagy is how cancer regenerates itself!

In this fashion, the cancer becomes a never ending string of chain reactions. This system is replete with cannibalism. Plus it features never ending supplies of combustible smog capable of refueling and further intoxicating the quartet while choking the surround normal cells.1, 11, 12, 14, 24
But can this lurid tale from a house of horrors tell us how to silence the strings to this never ending series of chain reactions? Yes it can, but only after everything is placed into the correct context...
To recap:
A. The first engine = the Viola, which = Dante's lost souls, that operate under a carburetor requiring low oxygen, low octane fuel, which = the rogue placenta (that most oncologists think of as the only kind of "tumor" cells), and thrives under autophagy.24
B. The second engine = the Violin, which = Dante's beast Cerebrus, that operate under a carburetor requiring high oxygen, high octane, which = the rogue embryo (that most oncologist fail to recognize as cancer's deadly stroma), and thrives under an absence of apoptosis.24
C. The tunes of the Cello leads to è excessive paralyzing inflammatory agents.(I), 7, 31
D. The vibrations from the Double Bass leads to è paralyzed immune cells.31
E. The Molotov cocktails are everything above crashing together, laced with aggressive microbes such as Candida.(A), 5, 6, 23, 25, 26
F. The first engine recycles everything above through true cannibalism termed autophagy,13 regenerating the entire cancer quartet.24
What remains now is for these five defining elements composing and orchestrating cancer's turf to be placed into the "context" of the top eight causes to cancer as initially listed above. Once done, the Achilles' Heel can be identified. Once identified, the Achilles' Heel is then addressed by the Four Pillars. Finally Eclectic Oncology directs the patient to perfect the Four Pillar approach to the extent that the patient achieves The Regeneration Effect within... Once achieved, final extinction of cancer's quartet is accomplished.9, 22, 23
So now it's time to definitively turn the tables - first by draining the swamp, then by returning fire,
while in tandem quickly amassing an overwhelming military force!
As the patient's body amasses its overwhelming military force, the tide must shift rapidly. This tide within the patient's body must now fall exclusively in favor of supporting healthy cell growth. And this shift in tide must give no quarter to future rogue cell survival.
To shift the tide tactically, the initial objective of Eclectic Oncology now focuses on measures to remove all of cancer's home court advantages instilled within its turf. Therefore, the initial objective is to extinguish ALL the Molotov cocktails.
To accomplish this, two strategies must be employed at the same time:
1) Powerful fire extinguishers must be employed 24/7 (see the sub-tab "Aspirin for Cancer" in the upper left corner of the "Education" tab above), and
2) The fuel sources of the Molotov cocktails must be cut-off and diverted. That is, you drain and clean up the swamp. Now the quartet of cancer's string instruments find themselves in the empty vacuum of deep space.23, (P), (Q)
And so with no air to vibrate, ALL their respective strings fall dead silent. But the cancer quartet still remains. Enter now - The Three Furies...

With these three Furies properly unleashed and directed, one gains time and important footing against cancer's quartet. This provides the cover for one needing to buy the time it will take to amass an overwhelming military force to fully eradicate oneself of cancer. This is done by laying down a 24/7 blanket of "cover-fire." The cover-fire is arranged in a very special way so as to ambush the quartet via three separate cross-fires illustrated above as our "Furies," which specialize in tearing themselves apart from the outside in and inside out:
3) The first engine is vulnerable to blowing up if autophagy becomes short-circuited by way of overload.24 We term this lethal or "catastrophic" autophagy. The capacity for catastrophic autophagy falls under the control of innate mechanisms within the body whose purpose is to re-establish control over rogue recycling of cell debris. Under strategies utilized by Eclectic Oncology, all-natural tools are employed which may excite this innate wisdom of the body to overload such rogue cell recycling, with little harm to normal healthy cells.
4) The second engine is also vulnerable to blowing up, in this case by re-establishing apoptosis under the cell's autopilot control which suffers from amnesia. Under strategies utilized by Eclectic Oncology, normal healthy apoptosis may become fully reawakened, thereby shutting down this second engine.12
5) Eclectic Oncology then goes one step further helping to insure these two engines never operate again. This is done in many cases by turning up cancer's very own system of necrosis using all-natural means. Typically, necrosis only occurs at the outside layers of quickly growing tumors, and does nothing to harm the most dangerous inner tumor layers. However, there are strategies that "induce" and/or "amplify" necrosis (called necroptosis)(T) throughout the tumor site.14
In summary, the three Furies are fully unleashed to gnaugh and gnash away at the rogue placenta cells and rogue embryo cells until their self-destruction, by combining:
(I) necroptosis strategies with apoptosis strategies, and then combining
(II) necroptosis tools with strategies that induce catastrophic autophagy.
In this manner, the percentages of sustainable recoveries may dramatically improve.(P), (Q)
The next three objectives are to provide the patient with:
6) A method to fully sensitize (mature) and fully enhance the patient's own immune system (to develop permanent immunity to the specific cancer involved and to achieve optimal clearance of infectious microbes),39, 40, 41 plus
7) Techniques of mind over matter,(S) as well as
8) Protocol alternatives if necessary, matching to the resources of the patient.
Eclectic Oncology is the first to bring these eight wonderful strategies - all working in tandem - to the general public.
However, Eclectic Oncology is most concerned with the proper follow-through to prevent recurrence.
This tandem approach is quite novel, and utilizes only all-natural products or tools that are consistent with identical or similar tools used for thousands of years by the long-lived pta-peoples from around the world. But even this alone is insufficient to get the job done. One must restore The Regeneration Effect within èèè day in, day out, night in, night out, for the rest of one's life.
Therefore:
9) The final objective of Eclectic Oncology is to permanently enable the mind and body to never again allow the performance of cancer's quartet. In this light, Eclectic Oncology educates the recovered patient on how their milieu or turf must be cleaned out and restored daily, while living a good life emphasizing optimal mental attitudes.
Only in this manner will our milieu exclusively nourish normal healthy cell growth - as opposed to ever again - reconstructing, fueling & igniting such rogue placentas and rogue embryos.
Interestingly, it should come as no surprise that the causal approaches utilized by Eclectic Oncology to overcome solid tumor cancers produces equally positive responses for the blood borne cancers. Fundamentally, this is because Eclectic Oncology gets the patient's own body to cure itself.
However, in the case of blood borne cancers, more care must be given to rapid cell die-off, or what is also called tumor lysis syndrome (TLS).33 This appears to be at least in part due to: (A) higher loads of blood borne pathogens which are tricky to detect,5, 6 and/or (B) high exposures and/or saturations with toxic chemical residues and/or radioactive particles.32, 58 To best elicit the ideal body response, Eclectic Oncology incorporates:
(1) A quenching protocol,
(2) Reducing infectious loads in a well paced manner, plus
(3) Comprehensive detoxification procedures to best manage blood borne cancers.
In this manner, the final targets, their strengths, their vulnerabilities, and the means to their final defeat can be properly ascertained for all cancers: carcinomas, sarcomas, lymphomas and leukemias.
Therefore, by:
(1) Short-circuiting cancer's dual - yet distinct - survival engines,
(2) Detoxifying & quenching cancer's three main fuels - hypoxia, hyperacidity & inflammation, and
(3) Restoring optimal infectious clearance & immunity...
...the human body may cure itself of this scourge.(A), 11, 22, 23, 24, 25
Eclectic Oncology teaches that in order to prevent cancer from ever returning, inducing The Regeneration Effect across all cells, tissues and organs, seals a lasting cure. This includes inducing The Regeneration Effect across the entire field of the mind as well. And we induce The Regeneration Effect by way of proper daily use of the Four Pillars as established by:
(i) humanity's longest lived cultures,15, 20
(ii) extensive animal studies,18, 19 and
(iii) multi-decade laboratory investigations.21, 22
Pacing the process properly is the key to short term, intermediate term and long term success
One critical requirement why The Regeneration Effect must be fully instituted during treatment is this... If the body elects to dissolve the tumor very quickly, and it just so happens that the tumor is wrapped around and eaten into a wall or vessel of some import, this could present major challenges. Therefore, only well-paced, regenerative, non-caustic approaches can properly address this potential complication in real-time, as opposed to costly reparative surgery after the fact.(M), 11
We call this method of regenerative therapeutics Applied Colloidal TherapeuticsTM
(ACTTM - see our Education page and then sub-tab for ACTTM to the upper left).

Today, Eclectic Oncology is one key discipline within Eclectic Medicine that researches, develops and utilizes ACT'sTM most advanced methods that enable patients to cure themselves of advanced cancer states.
It is the mission of the ICCTTM to teach Eclectic Oncology to the leading group of natural health care providers wishing to perfect their clinical expertise in managing patients suffering from advanced cancer.
The goal is not to teach that the doctor cures the patient of their advanced cancer, but rather that the patient's own body may accomplish this if properly supported and guided. To accomplish this goal, the ICCTTM will train, with precision science and metrics, how to master the discipline of Eclectic Oncology. (See the "ICCT" sub-tab under the "Education" main tab above.)
So, in brief, let's begin here and now for those professionals browsing this section:
Technically speaking, cancer is a paired duet complex or "quartet" consisting of a milieu in chaos and crises. The chaos involves cellular constitutional defects,(A), 9 and the crises involves inflammation, hyperacidity and hypoxia typically associated with microbial co-morbidities.(A), 11, 34, 35 Within this milieu exists dual - but different -embryonic metabolisms not unlike (a) an invasive placenta feeding, protecting and regenerating a (b) rogue/deformed embryo.24 Specifically, on one end of the first duet is:
(1) a dedicated oxidative glycolysis system - the Warburg Effect - which is fungalmimetic (i.e., is fungus-like, hypoxic and hyperacidic which is lactate loving). Its exclusive purpose for existing is to feed...
(2) a separate 'codependent' oxidative phosphorylation system (which is high oxygen, pyruvate & short chain fatty acids loving).
Think of the first half of cancer's quartet this way - because this oxidative glycolysis system has the exclusive purpose to fuel & regenerate the second via a regenerating mechanism termed autophagy, it possesses the machinery powerful enough to repair almost everything conventional oncology throws against it. And this goes a long way to explain the reason why 97.7% of the time cancer develops complete resistance to chemotherapy (see our Other Compelling References section below). In other words, this unholy dual tumor engine complex forms a perfect union to either evade or develop resistance to conventional cancer treatment regimens.(A), 1, 13
Furthermore, the second duet within the cancer quartet involves both: (3) immune deficiency on one end and (4) a conflicted immune hyperactivity on the other end. Such a cancerous milieu typically propagates insidious (overlooked & hard to detect) infections such as Candida albicans. This in turn then sets the stage for the inflammatory end-products of the microbes to fuel and ignite the cancer state within human cells - true Molotov cocktails to the surrounding healthy tissues.(A), (I), 5, 6, 11, 25
For example, Candida albicans secretes inflammatory mycotoxins which turn off our most protective anti-cancer genes, such as p53. This leaves normal body cells largely helpless to prevent conversion into the cancerous state. Additionally, Candida will often trigger aggressive immune cells to over produce inflammatory growth factors (pro-inflammatory cytokines) and free radicals adding to the turf war. Retrospective research conducted by the ICCTTM has not only confirmed these findings, but also the best all-natural strategies to overcome this insidious breeding ground for opportunistic infections so integral to cancer's quartet (via Eclectic Oncology).(I), 26
Eclectic Oncology recognizes that because cancer can feed itself through these two very different systems typically laced with insidious infections, it is necessary to use select all-natural tools and procedures that comprehensively address all milieu components in a precise sequence. Additionally, dietary selections (which must reconcile the ability of cancer's quartet to access ALL incoming food groups, and not just carbohydrates & sugar as many believe) must be carefully selected to: (A) match and synchronize to the specific therapies being given, as well as (B) to the patient's current metabolic status. More specifically, great emphasis is placed upon raw food factors that are both delicious and nutritious to consume, yet are fully loaded for war against tumor cells. Thus, Eclectic Oncology seeks to enable the patient's body to conquer cancer from within, akin to how the ancient Greeks conquered Troy by constructing a great Trojan Horse.
When properly selected, such an eclectic approach acts not unlike an elite - counter-intelligence - special ops team. Put another way, Eclectic Oncology selects very specific menu items which (I) support the most efficient expression of the patient's healthy metabolism, while (II) infiltrating & overloading the cancer engines through their respective Achilles' Heel. Interestingly, all Achilles' Heels have the same choke point, but each respective choke point must be approached through at least two different strategies in stages which impact the quartet in a cumulative manner. In every sense of the word, these Achilles' Heels enable 'Trojan Horses' to burst into the inner sanctums of any given cancer cell at any stage of development. Optimally, each Trojan Horse must be loaded & bristling at the seams with multiple synergistic choking agents all matched to the specific engine type they must seek out and destroy. Altogether, Eclectic Oncology matches the precise tools which address all sides of the quartet at a pace the patient can handle.(P), (Q), 23
Finally, because Eclectic Oncology seeks first and foremost to strengthen the patient's constitutional state with The Regeneration Effect (see our Mission Statement, then the "ACT" sub-tab under our "Education" main tab), it gleans an unprecedented advantage over the cancerous state. For example, inducing unscheduled fibroblast repair while insuring for homeostasis and epigenetic integrity fosters tissue regeneration which punitively impacts the formation of cancer or its continued survival.21, 49-53 Then, by coercing the tumor cells to readily assimilate foods impregnated to choke & suffocate both the invasive placenta as well as the rogue embryo, it gleans its second major advantage over the cancerous state. The coercing strategy would necessarily involve treatment protocols sensitive to chronobiology.47, 48 Thirdly, Eclectic Oncology selects dietary items and nutraceuticals that restore immunity in a properly paced sequential manner over sufficient time to regenerate tissues (12 to 24 months in all).9, 10, 21 Finally, all inflammatory pathways are quenched at not only their source, but also at their locations by upregulating targeted detox elimination channel(s). This finishing touch enables the patient's own immune system to complete the job and prevent recurrence.11, 39-41.
Conventional oncology simply cannot compare in this regard.
Up until now, conventional oncology has had a difficult time solving the riddle as to precisely what is & what is not the cancerous state, especially in regard to its milieu.34, 35 Thus, conventional treatment development has consistently ignored critical extracellular and intracellular milieu factors to the great detriment of the patient's own immune system.(A), (D)
Indeed, conventional oncology's strategy of "cut, burn and poison" is frequently devastating to the patient's remaining healthy tissues and milieu. In fact, fatalities from conventional treatment (and not from the cancer) approaches 40%! And of these iatrogenic deaths, approximately one-half will occur within the first 30 days of conventional treatment because they are so caustic to normal cells.(K), 17
But if the patient does survive past the first 30 days of such intense toxic overload, these same approaches can still be fatal at a later date to the patient's immune system. Then desperate methods are called in (at great expense and pain) in an attempt to restore it before the patient dies from opportunistic infectious disease. Commonly, this requires that the patient undergoes bone marrow transplantation (BMT). However, too frequently and unacceptably BMT brings about rapid death as well. Specifically, such fatalities from BMT account for up to 26% of the overall number of patients dying from the treatments themselves (and not the cancer).(F)
And for children, the after affects of conventional treatment can be devastating, even after being declared cured. For example, according to a report published in the New England Journal of Medicine, conventional treatments for childhood Hodgkin's disease are 18 times more likely to later develop secondary malignant tumours. Girls are at great risk too. 35 per cent of young girls treated for Hodgkin's disease with conventional methods should expect to develop breast cancer on or before they reach 40 years of age. This astoundinng figure is 75 times greater than the risk of developing breast cancer for women in general. The risk for developing leukemia increases alarmingly at the four year post-treatment mark and continues to increase in risk until the 14th year. Beyond that, the increased likelihood of developing secondary solid tumors remains high (approaches 30% of all patients treated conventionally as a child for Hodgkin's disease), at the 30 year post-treatment mark.42 Between these horrific figures, it gives us all pause to ask if there were not a better way of going about this?
Fortunately, Eclectic Oncology does not employ immune destructive tools
and therefore enjoys freedom from tempting such a fate.
But if one does not understand how healthy or cancerous tissues actually work at the cell and below cell level, nor understand the true nature of the healthy milieu or unhealthy milieu, it makes sense why such conventional strategies have been so dogmatically employed as they have for so long. That is, researchers in drug development do not ever pause to reflect on how to develop better ways to go about destroying cancer that simultaneously protects, restores and regenerates the patient's immune system. This is because they have no idea how to do both at the same time. And this is due in large part to an absence in understanding true cell physiology of living cells (not stained or altered by unnatural conditions), as comprehensively discussed by Gilbert N. Ling!(D)
Briefly, let's discuss a few of the more befuddling aspects to the milieu of cancer...
As far as the cancer cell itself is concerned, few have realized that the conventional understanding (as to how things are transported into and out of cancer cells) is simply, for the most part, all wrong!(D), (N) And if this statement is true (and it is), then how are we to possibly determine the actual workings of any drug being employed to kill cancer and yet simultaneously spare normal healthy cells in the process? Well, the answer is, we cannot. This dilemma, above all else, is the reason for using (as our best scientific reference), the traditional herbal remedies (phytomedicines) of the pta-peoples from around the globe. These phytomedicines are tried, true and tested over thousands of years. Hence, phytomedicines are a perfect means to achieving targeted cancer cell death while supporting the simultaneous restoration of the person's immune system. And this is why phytomedicine is the backbone to Eclectic Oncology as well as to Eclectic Medicine in general. But the complete framework to the eclectic paradigm remains the Four Pillars, also as practiced by all the long-lived pta-peoples from around the globe (see "Diseases FAQs" main tab above).
Despite this 5,000 year paradigm of traditional medicine, conventional oncology has counter-intuitively turned a blind eye toward phytomedicine unless made into a patented drug. Patented drugs are devoid of their original potent, yet predominantly safe, chemical characteristics as found in medicinal herbs.
In summary, the chemical state of phytomedicines properly extracted from medicinal herbs has evolved over millenia right alongside the human genome, making them highly compatible. Our genes are familiar with medicinal herbs because they both derive from the living state, which is "colloidal" in nature. Phytomedicines largely produce colloidal reactions which are predominantly compatible with our 'living' cellular chemistry because it too runs predominantly off of colloidal chemistry. But synthetic drugs operate under a different chemistry governed by 'salt' chemsitry, which is also called crystalloidal chemistry. Salts and colloids operate in different chemical universes or fields, and salts over time and in sufficient quantities literally 'collapse' colloids. And this in the main explains why chemotherapy is so prone to inducing iatrogenic death rates as high as 40% in all conventionally treated cancer patients!. It also explains why chemotherapy, used in monotreatment, is only 2.1% to 2.3% effective in battling cancer, as extensively documented at the bottom of this page.
Indeed, with chemotherapy being such a dismal failure, yet being so highly toxic to healthy tissues at the same time, is it any wonder why we continue to see escalations, decade after decade, in overall cancer deaths? Yet, many fervent believers in such a system (believers because they do not even fully fathom cancer cell physiology at all), spin statistics all day long desperate to prove that "success rates" have substantially risen over the last three decades. Really??? How can the key megatrends in cancer show death rates horrifically increasing overall in the past 60 years, while the most common kinds of cancer being treated conventionally purportedly show dramatic improvements in survival??? The answer is with a lot of "spin" of course. Historically and repeatedly, once fair & proper no-spin analysis is given to unwind such flawed statistical analysis, the truth not only shocks the conventional community, but hurts the truly sincere professionals in this field who have dedicated their entire careers to find the ever elusive "cure."(E) (See Other Compelling References of Interest in reference section below.)
The no-spin truth is, cancer can never be 'cured' by further mucking up its turf.
Mucking up cancer's turf simply sooner or later facilitates the growth of more cancer with a vengeance. In essence as far as the milieu to the quartet of cancer is concerned, it self-sustains itself in such a way as to blur any clear cut barriers between normal cellular biology, cellular pathology and microbe pathology. The pro-inflammatory agents plus the highly toxic free-radical peroxynitrite facilitate this self-sustaining muck. Put another way, cancer cells often act as though they were chameleons in such degenerated milieus, as do many microbes. This feat of both human cells and microbes acting as chameleons is known as pleomorphism, meaning cells of many shapes which love to "morph" into ever changing stages of differentiation.(A), (J), 2, 7, 11, 30
In plain language, pleomorphism is the haven of The Great Imposters.
And the Four Pillars is the means to enable purging their unholy haven from the human body.
Pleomorphism infiltrates into the normally well defined biology of the organism at the cell and below cell levels. This pleomorphism is so pervasive that it obfuscates and befuddles standard conventional investigations to determine what is and what is not actually occurring at the tumor cell and below tumor cell level.3, 4, 5, 6, 7
In order to properly assess what is truly taking place in such a pleomorphic state, we must first enter into the world of what Gilbert N. Ling has called, “The Hidden History of a Fundamental Revolution in Biology.” For the record, Gilbert N. Ling should be regarded as the Nikola Tesla of Cell Physiology. What Ling has been alerting the entire medical and scientific community about for over 40 years is simply this... by not correctly understanding what the real core components and dynamics are to the cellular milieu (both internal and immediately external to the cell), cancer hides it true nature and therefore obscures treatment development for its final cure.(O), 8
To summarize bluntly,
cancer can only be 'cured' by converting its turf into Shangri-la, not more barren wasteland!
In summary from a technical viewpoint - Cancer must be simultaneously treated by addressing its quartet nature, both at the cell and below cell level, while modulating its milieu to the higher order (into the "high gain" energy state). It is this high gain energy state which causes healthy cell differentiation as opposed to unhealthy cell differentiation. To perfect the high gain energy state requires the Four Pillars operating optimally. Once perfected, The Regeneration Effect is fully restored. Only in this manner may cell physiology acquire and permanently retain the ideal cell differentiation states as exemplified by the cancer-free Peoples of the Blue Zones. Perfecting such a treatment regimen epitomizes the Art & Science of Eclectic Oncology.(J), 8, 9, 10, 15, 18, 20, 22

The International College of Colloidal TherapeuticsTM (ICCTTM) has brought forth Eclectic Oncology into the 21st century. Eclectic Oncology does not treat cancer. It restores The Regeneration Effect within while simultaneously focusing this heightened self-healing power to direct fullest attention to the cancer state at a pace the patient can well tolerate.
Thus, cancer patients cure themselves,
not the eclectic physician and certainly not the eclectic protocols "per se."
Rather the patient's cellular state rules over the end result.
Overview of What You Can Do Now
Initially there will be a vertical learning curve for folks wishing to arm themselves with all-natural eclectic techniques concerning cancer. The patient's own Regeneration Effect is the most important starting and ending point. To restore The Regeneration Effect within:
Initial Program must include a series of 10 colonics at a licensed healthcare facility. And if you can afford it, a water structuring filtration system (see my Essential Links homepage for more information).
Next - read the book - Hypothyroidism Type 2 - by Mark Starr, MD.16
Third - go to my "Getting Started" tab, learn and implement. However, emphasize low carbohydrate foods until you get further information on my eBook series (see below). This means using low amounts of most fruits for the immediate time frame. Emphasize cottage cheese with flax seed oil (as per the new book - http://www.cancerfreefoods.com/order.html?hop=staywell) and use at least 6 stalks of organic asparagus in each of your smoothies. Read below under "Implementation" the six requirements (A through F), then complete the eight objectives by undergoing the 12 Step Protocols that will be covered in my eBook series.
What should I do if I suffer from cancer?
The truth is, your mind/body is its own best healer (the mind and body are inseparable; they are one in thought, word and deed). Provide it what it needs, then
step aside.
By going to my "Getting Started" tab, you can begin to learn the ropes. It's that simple.
Pay special attention to the digestive aids discussion, as well as the diet instructions.
When our eBooks become available, be sure and consider this resource as your main educational curriculum.
By taking your basal underarm temperature before you get out of bed each morning, you can see if your thyroid may be low. The normal underarm temperature is
98.0oF ± 0.2oF. Until your levels of body thyroid hormone become optimal, weight gain will always come at a price, that is, once you loss it, it will come back. With
each subsequent successful weight loss effort, it becomes more and more difficult to loss the weight and easier and easier to gain it all back. Proper thyroid
hormone levels stops this so long as a proper diet and exercise program are adhered to for life.
Use positive attitude techniques EVERY DAY!(L)
If you continue to experience difficulties, then it's time to browse over my "Essential Links" tab for further resources.
For those with advanced cancer states wishing to implement the ICCTTM "home-based" Regeneration Effect program
utilizing the Four Pillars, the most ideal pre-requisites for optimal results would include:
A. Being no more than 70 years of age with a history of being breast-fed as an infant;
B. An absence of bone cancer AND possessing all vital organs which have not been fatally compromised or poisoned at the time of initiating the 12 Step protocols
(including an absence of dental iatrogenesis, i.e., no amalgam fillings, root canals or crowns, metal bridges, etc...(B));
C. Having a prognosis of at least one year or longer to live;
D. Having a trusted companion(s) who can assist in the recovery process for the long term;
E. Possessing the resources to procure the necessary eclectic tools from reputable suppliers of choice;
F. A willingness to fully commit to an intensive 12 Step protocol series for 1 year (including detoxification procedures such as colonics and enemas). Plus after recovery,
the former cancer patient should commit to another year to perfect The Regeneration Effect within, in order to sustain optimal health and prevent recurrence.
Other patients who possess less than the above ideal pre-requisites may still partake and greatly benefit from The Regeneration Effect. That is, with the understanding they have further to go and harder to work,
in order to maximize and enjoy as great a probability of ideal outcome.(G)
The eBook and printed series includes:
The Regeneration Effect: Curing (verse Controlling) Terminal Cancer - Volume 3:
Due out late 2011.
Implementing Eclectic Oncology involves individualized sequencing of steps to a full recovery. The 12 Step protocol series is designed with this in mind. Everyone who suffers from advanced cancer is different. Their "kind" of cancer may be different; their "stage" of cancer may be different from the next case; and their previous conventional or complementary treatments may be different; and the patient's constitutional state may be very different from other cases. What unites these differing situations is the underlying cancer state. And what unites all the differing kinds and stages of cancer is what can be defeated by the same strategy. This holds true so long as it is administered properly according to the individual's constitution, special needs, resources and tolerances.
From start to finish, the implementation of the Regeneration Effect is designed to:(L), 9, 10, 11, 12, 13, 14, 15
1. Buying time (Slow & Stop the Spreading);
2. Restoring and regenerating non-cancerous tissues by regenerating the milieu and mind;
3. Swiftly modulating the cancer milieu back into a healthy and optimal (high gain) state by first eliminating all inflammatory pathways;
4. Exploiting cancer cells' self-programming to select death by restoring optimal apoptosis at a well-tolerated pace);
5. Exploiting cancer cells vulnerable mechanisms it depends upon to regenerate the cancer state by inducing catastrophic autophagy at a well-tolerated pace;
6. Exploiting cancer cells' necrosis mechanisms by inducing catastrophic necroptosis at a well-tolerated pace;
7. Restoring global immunity against cancer while ensuring the full expression of The Regeneration Effect within;
8. Maximizing regeneration within aging body cells, tissues and organs to revitalize the individual's constitutional state enabling essentially disease-free living up to 90 years of age and beyond, starting with the power of the mind, just like folks do today who inhabit the Blue Zones around the world.
The ICCTTM is committed to collecting results from qualified participants who properly adhere to the 12 Step protocol series. By helping us to keep careful documentation of results, this will assure the protocol series may achieve its goals to achieve highest probability of total success. You can help in this effort by first undergoing these protocols under the supervision of a qualified doctor of eclectic oncology, and then by making your successful case history apart of our official records. The ICCTTM will maintain strict confidence as to your identity along all points when publishing the clinical outcome results.
Essential Reading:
1. Regeneration Effect Volume 1: eBook soon to be released on this website.
2. Hypothyroidism Type 2 by Mark Starr, MD.16
References:
____________________________________________
* See: http://davelafferty.com/
** Courtesy of JT Design.
(A). Localized regions which favor both microbe entrenchment and the cancer state are characterized by a "field effect" which generates genetic instability within cells. For example, the dual nature recently
discovered endemic to tumor cells depicts a co-existence of two very different metabolically irregular & variant cell forms both stemming from human fibroblasts (Martinez-Outschoorn UE, et al. Oxidative
stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle. 2010 Aug
15;9(16):3256-76. Epub 2010 Aug 28). This genetically unstabilizing field effect would appear to be what highlights recruitment of normal cells into rogue cells plus cancer stem cell migration (Ahmed N,
Abubaker K, Findlay J, Quinn M. Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer. Curr Cancer Drug Targets. 2010 Apr 6).
When this genetic instability reaches a certain threshold, cells morph into bizarre forms, which exemplifies 'pleomorphism.'
Pleomorphism is defined as the "existence of irregular and variant forms of the same species or strain of microorganisms." According to the textbook Biology, "Many fungi, particularly those that cause
disease in humans, are dimorphic, that is, they have two forms" (C. Villee, et al. Biology, NY: Saunders, 1985).
Likewise, cancer cells themselves are known to be pleomorphic as well (Yoda A, et al. Two cases of pleomorphic carcinoma with severe systemic inflammation. Nihon Kokyuki Gakkai Zasshi. 2009 Aug;47
(8):751-7.). When these two irregular and variant forms of human and microbe cells intermingle, things can get very obfuscated. For example, consider the filamentous variant of Candida albicans which
mimics cancer! (Shibata T, et al. Oral candidiasis mimicking tongue cancer. Auris Nasus Larynx. 2011 Jan 11.[Epub ahead of print]). Thus, pleomorphism drives, complicates and determines both
immunological as well as pathological events in ways not presently completely understood. Any successful approach intending to actually "cure" cancer once and for all, must strategically & properly
reconcile pleomorphism to effect a permanent solution.
These fundamental principles & factors that determine both healthy & unhealthy cell expression are the real genomics and proteomics which we must know to cure cancer. Such genomics and proteomics
define the Art & Science of Eclectic Oncology.
For a thorough historical review of the co-dependent arising of infections and cancer, their true causations & what facilitates both (i.e., the low gain, low energy, chaotic cancer milieu which precedes
both), see: http://www.thefreelibrary.com/Cancer+and+infection-a0186862945.
(B). Carefully review the Biological Dentistry sub-tab, including Dr. Cook's marvelous new eBook - Rescued by My Dentist.
See: http://www.amazon.com/Rescued-My-Dentist-solutions-health/dp/1425170919.
(C). Presentation entitled, Oncogene Proteins and Oral Toxicity by Bob Jones, PhD - Cavitat Seminars; with Tullio Simoncini, MD; Dallas, TX, October 25th-27th, 2008. For more information,
see: http://www.drshankland.com/page11402151.aspx#4
Plus: http://jnci.oxfordjournals.org/content/early/2010/12/28/jnci.djq516.full.pdf then see: http://www.tldp.com/issue/157-8/157rootc.htm
For documentation revealing Candida albicans (oral Candidiasis) is a common pathogen within tooth root canals (osteonecrosis), see: Miranda TT, et al. Diversity and frequency of yeasts from the dorsum
of the tongue and necrotic root canals associated with primary apical periodontitis. Int Endod J. 2009 Sep;42(9):839-44.
For documentation that oral Candidiasis is associated with suppressing the anti-cancer gene p53, see: Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med. 1995;6(2):147-60; and see: Gao Y. Aberrant
p53 protein expression in oral candidal leukoplakia. Zhonghua Kou Qiang Yi Xue Za Zhi. 1996 May;31(3):182-4.
For more on this critical subject covered in book format, see: http://www.drshankland.com/page12801335.aspx
(D). For immediate resources on what you can do right now, go to my "Getting Started" tab, then my "Essential Links" main tab, then see all four of the top sub-tabs (on the upper left).
(E). See: www.gilbertling.org
(F). See: http://www.ralphmoss.com/html/reviews.shtml
(G). Even though there has been a welcomed drop in deaths and injuries over the past several decades from bone marrow transplants (BMTs) and stem cell transplants (SCTs), the overall death rates and
complications from them remains unacceptably high, as high as 26% of recipients (Gratwohl A, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias:
an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005 Nov;36(9):757-69.).
Also see: http://www.ehow.com/about_5488722_risks-donors-bone-marrow-transplants.html
And: Dublin BMT infection contamination.pdf
And: Lethal Events from BMT.pdf
(H). Depending upon each individual's circumstances, results will vary, and no guarantees can be made any one individual will experience the results of what many others will achieve.
(I). See: http://www.cancerisafungus.com/
(J). In developmental biology, cellular differentiation is the process by which a less specialized cell becomes a more specialized cell type. Cancer cells are less specialized than healthy cells, and vice versa.
(K). Iatrogenic death means "doctor induced death" or "physician caused death."
(L). See: http://2011tappingworldsummit.com/2011_free_event_access.html and: http://www.2011tappingworldsummit.com/VideoSeries/?page_id=60&blog_prm=6465
(M). For example, Dr. Cham has documented how an extract from Devil's Apple can easily cure up to 97% of most skin cancers, except melanoma, without leaving behind the devastating effects of surgical
scars and facial deformities. See: http://www.amazon.com/Eggplant-Cancer-Cure-Treatment-Pharmacy/dp/1890572217/ref=sr_1_1?ie=UTF8&s=books&qid=1297185430&sr=1-1
(N). In 1997, J.C. Skou was awarded ½ the Nobel Prize in chemistry for his work concerning the “Sodium pump.” He promoted his theories beginning in the late 1950's BEFORE the advent of modern MRI
technology. Beginning in the 1970's, MRI would prove Skou's theories incorrect. So Skou's obsolete methods allegedly proving his theories is hardly proof of a workable Na+/K+ pump theory for cell
physiology. In essence, for the 1997 Chemistry awards, the Nobel Prize committee did not do their homework, which just goes to show us that we are all human.
For example, if one were to run with the sodium pump as justification for a Na+/K+ pump, it would take at least 15 to 30 times more available energy to run the sodium pump than what is actually
available within a cell. (See Table 2, Chapter 12, page 111, in Ling’s book – Life at the Cell and Below Cell Level: The Hidden History of a Fundamental Revolution in Biology. Plus see: www.gilbertling.org
and scroll down to the section entitled “They Did It Again.”) This begs the question – if your car engine required 15 times the amount of gas to get you to your destination than your gas tank could hold,
would you trust it to get you there?
Put most succinctly, Skou’s Nobel prize in chemistry invalidates the Law of the Conservation of Energy! This charge has been thrice confirmed in the authoritative literature long before Skou was awared
his Nobel (see: Jones AW. PhD. Thesis, Univ. of Pennsylvania, 1965; Minkoff L, Damadian RV. Biophys. J. 1973;13:167; and Minkoff L, Damadian RV, Biophys. J. 1974;14:69), and in two other refereed
tomes published by Ling. See: Ling GN. Debunking the alleged resurrection of the sodium pump hypothesis. Physiol Chem Phys Med NMR. 1997;29(2):123-98.
To the greatest extent imaginable impacting practical applications to how cells import and export, conduct genomic and proteomic functions and structure the cell's constitution, this (A)
unsubstantiatable concept of a Na+/K+ "pump" run by cellular reserves of ATP energy - or more correctly by (B) Ling’s A-I Hypothesis substantiated over 40 years and never refuted - is arguably the
most important fulcrum to pharmacology of all time. It is the driving force to knowing how to select just the right agents to induce regenerative events or to induce immunity to cast out select
pathologies while taking into proper account the effects on normal healthy tissues. Where exceptions do arise - meaning that to date there are minor mechanisms which do involve substantiated
membrane pumps that do NOT violate the Law of the Conservation of Energy - Ling's A-I Hypothesis still rules the day, across all cells, tissues and organs.
(O). See: Gilbert Ling Lecture 21.ppt - This will take a moment to load so be patient.
(P). Documented in: The Regeneration Effect: Curing (vs. Controlling) Terminal Cancer - Vol. 3 Due out March 25th, 2011.
(Q). Documented in: Constitutional Medicine: Eclectic Oncology - Part I. Due out late 2012. (R). SAW = Structured alkaline water; cRFs = colloidal regenerative factors which only come from select raw foods..
(S). See: http://www.authorstream.com/Presentation/aSGuest9984-135251-postive-mental-attitude-critical-fo-optimal-health-spiritual-inspirational-ppt-powerpoint/
(T). Other authors may refer to induced necroptosis as "autoschizis," meaning "non-programmed cell suicide."
(U). See: http://www.breastcancerfund.org/assets/pdfs/publications/state-of-the-evidence-2010.pdf
Endnotes:
_________________________________
[1] Faguet GB. The War on Cancer: An Anatomy of Failure A Blueprint for the Future. Springer, Dorderecht, The Netherlands, 2008;pp.14 & 16. ISBN: 978-1-4020-8620-5.
[2] Davis D. The Secret History of the War on Cancer, Basic Books, NY, 2007;pp. x & xii. ISBN-13: 978-0-465-01566-5.
[3] According to Aaron Blair, Ph.D., the chief of the Occupational Epidemiology Branch in NCI's Division of Cancer Epidemiology and Genetics in June 17 issue of the NCI publication Benchmarks.
[4] Ardenne Mv. Oxygen Multistep Therapy: Physiological and Technical Foundations. Translated by Paula Kirby and Winfred Kruger, Geirg Thieme Verlag, NY, 1990. See: www.thieme.com. [5] Warburg O. On the Origin of Cancer Cells, Science, 1956;123:309-15.
[6] Ling GN. A new theoretical foundation for the polarized-oriented multilayer theory of cell water and for inanimate systems demonstrating long-range dynamic structuring of water molecules. Physiol Chem
Phys Med NMR. 2003;35(2):91-130.
[7] Cope FW. Pathology of structured water and associated cations in cells (the tissue damage syndrome) and its medical treatment. Physiol Chem Phys 1977;9(6):547-53.
[8] Ling GN, Kolebic T, Damadian R. Low paramagnetic-ion content in cancer cells: its significance in cancer detection by magnetic resonance imaging. Physiol Chem Phys Med NMR. 1990;22(1):1-14.
[9] Cope FW. A medical application of the Ling association-induction hypothesis: the high potassium, low sodium diet of the Gerson cancer therapy. Phsiol Chem Phys 1978;10(5):465-8.
[10] Starr M. Hypothyroidism Type 2. See: http://www.amazon.com/Hypothyroidism-Type-Epidemic-Mark-Starr/dp/0975262408/ref=sr_1_1?ie=UTF8&s=books&qid=1267429210&sr=8-1
[11] Gerson M. The cure of advanced cancer by diet therapy: a summary of 30 years of clinical experience. Physiol Chem Phys 1978;10(5):449-64.
[12] Simoncini T. Cancer Is A Fungus: A Revolution in Tumor Therapy. Edizioni Lampis, Casale Marittimo (PI), Italy, 2005. ISBN:88-87241-08-2. Especially note the references from Chapter Four, pp. 230-3.
[13] Beard J. The Enzyme Treatment of Cancer, London, Chatto and Windus, 1911. See: http://users.navi.net/~rsc/krebsall.htm
[14] Webb SD, Sherratt JA, Fish RG. Mathematical modelling of tumour acidity: regulation of intracellular pH. J Theor Biol. 1999 Jan 21;196(2):237-50.
[15] Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Research. 1989 Aug 15;49:4373.
[16] Gray J. State of the Evidence: The Connection Between Cancer and the Environment. From Science to Action, with Janet Nudelman, MA, and Connie Engle, PhD, Breast Cancer Fund, Sixth Edition, 2010.
[17] Apsley J. Fukushima Meltdown & Modern Radiation: Protecting Ourselves and Our Future Generations. Temet Nosce Publications, Sammamish, WA, 2011.
[18] McCarrison R. Studies in Deficiency Disease. Oxford Medical Publications, Henry Frowde and Hodder & Stoughhton, Lancet Building, London, 1921.
[19] Pottenger FM. Pottenger's Cats - A Study in Nutrition. Price-Pottenger Nutrition Foundation, Lemon Grove, CA., 2009.
[20] Pitskhelauri GZ. The Long-Living of Soviet Georgia, Human Sciences Press, 1982 Feb; ISBN-10: 0898850738; ISBN-13: 978-0898850734.
[21] Carrel A. The Voyage to Lourdes, Introduction by Stanley L. Jaki, Real-View-Books, NY, 2007 (originally published by Harper and Brothers, NY 1950). IBSN-13: 978-0-9641150-2-6.
[22] Meridian Tapping - Tapping World Summit, 2011. See: http://www.2011tappingworldsummit.com/2011_free_event_access.php.
[23] Conscious Living Radio: Psychoneurophysiology - The German New Medicine about Emotions and Cancer. See: http://www.consciouslivingradio.org/?p2=modules/blog/viewcomments.jsp&bid=4.
[24] Psychoneuroimmunity - The Power of Positive Thinking.
See: http://www.authorstream.com/Presentation/aSGuest9984-135251-postive-mental-attitude-critical-fo-optimal-health-spiritual-inspirational-ppt-powerpoint/
[25] Stindl R. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells. Med Hypotheses. 2008;71(1):126-40.
[26] Katanaev VL. The Wnt/Frizzled GPCR Signaling Pathway. Biochemistry (Mosc). 2010 Dec;75(12):1428-34.
[27] Martinez-Outschoorn UE, et al. The autophagic tumor stroma model of cancer or “battery-operated tumor growth:” A simple solution to the autophagy paradox, Cell Cycle, 2010 Nov 1; 9:21, 4297-306.
[28] Inui A. Recent development in research and management of cancer anorexia-cachexia syndrome. Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9.
[29] Baldwin C. Nutritional support for malnourished patients with cancer. Curr Opin Support Palliat Care. 2011 Mar;5(1):29-36.
[30] Miki C, et al. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci. 2004 Jun;49(6):970-6.
[31] Imtivaz HZ, et al. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest. 2010 Aug 2;120(8):2699-714.
[32] See: Candidiasis induces NF-kB.pdf.
[33] Monk CE, Hutvagner G, Arthur JSC (2010) Regulation of miRNA Transcription in Macrophages in Response to Candida albicans. PLoS ONE 5(10): e13669..
[34] Flavin, DF. Clinical-Patient Studies: A lipoxygenase inhibitor in breast cancer brain metastases. Journal of Neuro-Oncology. 2007 Mar;82(1):91-3.
[35] Marusawa H, Takai A, Chiba T. Role of activation-induced cytidine deaminase in inflammation-associated cancer development. Adv Immunol. 2011;111:109-41.
[36] Chong DL, Sriskandan S. Pro-inflammatory mechanisms in sepsis. Contrib Microbiol. 2011;17:86-107.
[37] Cancer and Infection. Presented at presented at: The 6th International Conference on Phytotherapeutics 2007. See: http://www.thefreelibrary.com/Cancer+and+infection-a0186862945
[38] Warburg O. The Prime Cause and Prevention of Cancer,” [Taken from the meeting of the Nobel Laureates, June 30th, 1966]. Lindau Lecture, English ed. by D. Burk, K. Triltsch, Wurzburg, Germany, 1969.
[39] Galluzzi L, et al. Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol. 2011;289:1-35.
[40]
[39] Shibata T, et al. Oral candidiasis mimicking tongue cancer. Auris Nasus Larynx. 2011 Jan 11;38(3):418-20.
[40] Yoda A, et al. Two cases of pleomorphic carcinoma with severe systemic inflammation. Nihon Kokyuki Gakkai Zasshi. 2009 Aug;47(8):751-7.
[40]
[41]
[42] .
[
1. Akar U, et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008 Jul 1;4(5):669-79.
2. Michelow P, Dezube BJ, Pantanowitz L. Fine needle aspiration of salivary gland masses in HIV-infected patients. Diagn Cytopathol. 2011 Jan 6. [Epub ahead of print]
3. Terada T. Pure sarcomatoid carcinoma of maxillary sinus and nasal cavity simulating malignant fibrous histiocytoma. Am J Clin Pathol. 2011 Jan;135(1):128-31.
4. Rao S, Latha PS, Ravi A, Thanka J. Ductal carcinoma in a multiple fibroadenoma: diagnostic inaccuracies. J Cancer Res Ther. 2010 Jul-Sep;6(3):385-7.
5. Mokaddas E, Burhamah MH, Khan ZU, Ahmad S. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect Dis.
2010 Oct 6;10:292.
6. Mikulska M, et al. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care.
2010 Dec 8;14(6):R222. [Epub ahead of print]
7. Yoda A, et al. Two cases of pleomorphic carcinoma with severe systemic inflammation. Nihon Kokyuki Gakkai Zasshi. 2009 Aug;47(8):751-7.
8. Ling GN. Life at the Cell and Below - Cell Level: A Hidden History of a Fundamental Revolution in Biology. Pacific Press, NY. 2001; especially pages 26-7..
9. Cope FW. Pathology of structured water and associated cations in cells (the tissue damage syndrome) and its medical treatment. Physiol Chem Phys 1977;9(6):547-53.
10. Gerson M. The cure of advanced cancer by diet therapy: a summary of 30 years of clinical experience. Physiol Chem Phys 1978;10(5):449-64.
11. Flavin, DF. Clinical-Patient Studies: A lipoxygenase inhibitor in breast cancer brain metastases. Journal of Neuro-Oncology. 2007 Mar;82(1):91-3. See: Flavin-Neuro-Oncology Article with pics.rtf
12. Serini S, Piccioni E, Merendino N, Calviello G. Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. Apoptosis. 2009 Feb;14(2):135-52.
13. Nguyen TM, et al. Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels. Cell Mol Med. 2009 Sep;13(9B):3687-98. Epub 2009 Feb 27.
14. Galluzzil L, Kroemer G. Necroptosis: A specialized pathway of programmed necrosis. Cell, 2008 Dec 26; 135:1161-3.
15. See: Buettner D. The Blue Zones: Lessons for Living Longer from the People Who've Lived the Longest. National Geographic, Washington D.C. 2008. ISBN: 978-1-4262-0400-5.
16. See: http://www.amazon.com/Hypothyroidism-Type-Epidemic-Mark-Starr/dp/0975262408/ref=sr_1_1?ie=UTF8&s=books&qid=1267429210&sr=8-1
17. See: NCEPOD-SACT Report.pdf
18. McCarrison R. Studies in Deficiency Disease. Oxford Medical Publications, Henry Frowde and Hodder & Stoughhton, Lancet Building, London, 1921.
19. Pottenger FM. Pottenger's Cats - A Study in Nutrition. Price-Pottenger Nutrition Foundation, Lemon Grove, CA., 2009.
20. Pitskhelauri GZ. The Long-Living of Soviet Georgia, Human Sciences Press, 1982 Feb; ISBN-10: 0898850738; ISBN-13: 978-0898850734.
21. Carrel A. Tissue Culture and Cell Physiology. Physiol Rev 1924;4:1-17.
22. Cope FW. A medical application of the Ling association-induction hypothesis: the high potassium, low sodium diet of the Gerson cancer therapy. Phsiol Chem Phys 1978;10(5):465-8.
23. Apsley J, Holtorf K, Gordon E, Anderson W, Buttar R. Has Nanotechnology Created A Universal Antimicrobial Agent?: Silver, Cancer & Infection Associations Part III. Townsend Letter. 2006 May;(274):95-8.
24. Martinez-Outschoorn UE, et al. The autophagic tumor stroma model of cancer or “battery-operated tumor growth:” A simple solution to the autophagy paradox, Cell Cycle, 2010 Nov 1; 9:21, 4297-306.
© 2010 Landes Bioscience.
25. Simoncini T. Cancer Is A Fungus: A Revolution in Tumor Therapy. Edizioni Lampis, Casale Marittimo (PI), Italy, 2005. ISBN:88-87241-08-2. Especially note the references from Chapter Four, pp. 230-3.
26. See: Candidiasis induces NF-kB.pdf
27. Ardenne Mv. Oxygen Multistep Therapy: Physiological and Technical Foundations. Translated by Paula Kirby and Winfred Kruger, Geirg Thieme Verlag, NY, 1990. See: www.thieme.com.
28. Ling GN, Kolebic T, Damadian R. Low paramagnetic-ion content in cancer cells: its significance in cancer detection by magnetic resonance imaging. Physiol Chem Phys Med NMR. 1990;22(1):1-14.
29. Ling GN. A new theoretical foundation for the polarized-oriented multilayer theory of cell water and for inanimate systems demonstrating long-range dynamic structuring of water molecules. Physiol Chem
Phys Med NMR. 2003;35(2):91-130.
30. Ahmed N, Abubaker K, Findlay J, Quinn M. Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer. Curr Cancer Drug Targets. 2010
Apr 6. [Epub ahead of print]
31. Flavin DF. Reversing Splenomegalies in Epstein Barr Virus Infected Children: Mechanisms of Toxicity in Viral Diseases. JOM, Second quarter 2006;21(2):95-101.
32. Casado FL, Singh KP, Gasiewicz TA. The aryl hydrocarbon receptor: regulation of hematopoiesis and involvement in the progression of blood diseases. Blood Cells Mol Dis. 2010 Apr 15;44(4):199-206. Epub
2010 Feb 19.
33. Walker DK, Held-Warmkessel J. Acute promyelocytic leukemia: an overview with implications for oncology nurses. Clin J Oncol Nurs. 2010 Dec 1;14(6):747-59.
34. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Research. 1989 Aug 15;49:4373.
35. Webb SD, Sherratt JA, Fish RG. Mathematical modelling of tumour acidity: regulation of intracellular pH. J Theor Biol. 1999 Jan 21;196(2):237-50.
36. Li Q, Chen H, Huang X, Costa M. Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes. Toxicol Appl
Pharmacol. 2006 Jun 15;213(3):245-55. Epub 2006 Jan 4.
37. Hughes WT. Systemic candidiasis: a study of 109 fatal cases. Pediatr Infect Dis 1982 Jan‑Feb‑ 1; (1): 11‑8.
38. Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol 1980 Apr;73(4):518-21.
39. Roda JM, et al., Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res. 2006 Jan 1;66(1):517-26.
40. Malmberg KJ. Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape? Cancer Immunol Immunother. 2004 Oct;53(10):879-92. Epub 2004 Jul 28.
41. Sun HX, Wang H, Xu HS, Ni Y. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity. Vaccine. 2009 Jun 19;27(30):3984-91. Epub 2009 May 3.
42. See: http://www.nejm.org/doi/pdf/10.1056/NEJM199603213341201. Bhatia S, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996 Mar 21;334(12):745-51.
43. Baldwin C. Nutritional support for malnourished patients with cancer. Curr Opin Support Palliat Care. 2011 Mar;5(1):29-36.
44. Elamin EM, Glass M, Camporesi E. Pharmacological approaches to ameliorating catabolic conditions. Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):449-54.
45. Inui A. Recent development in research and management of cancer anorexia-cachexia syndrome. Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9.
46. Ottery FD, Walsh D, Strawford A. Pharmacologic management of anorexia/cachexia. Semin Oncol. 1998 Apr;25(2 Suppl 6):35-44.
47. Sewlall S, et al. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv. 2010 Dec;7(5):370-88.
48. Eismann EA, Lush E, Sephton SE. Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology. 2010 Aug;35(7):963-76. Epub 2010 Jan 22. 49. Li P, Waldman SA. Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis. Cancer Biol Ther. 2010 Aug;10(3):211-8. Epub 2010 Aug 11.
50. Li P, Lin JE, Schulz S, Pitari GM, Waldman SA. Can colorectal cancer be prevented or treated by oral hormone replacement therapy? Curr Mol Pharmacol. 2009 Nov;2(3):285-92.
51. Bryant S. Regeneration and pattern formation - an interview with Susan Bryant. Interviewed by Richardson, Michael K and Chuong, Cheng-Ming. Int J Dev Biol. 2009;53(5-6):827-33.
52. Krizhanovsky V, et al. Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology. Cold Spring Harb Symp Quant Biol. 2008;73:513-22. Epub 2009 Jan 15.
53. Stindl R. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells. Med Hypotheses. 2008;71(1):126-40. Epub 2008 Feb 21.
54. Murakami M. Lipid mediators in life science. Exp Anim. 2011;60(1):7-20.
55. Katanaev VL. The Wnt/Frizzled GPCR Signaling Pathway. Biochemistry (Mosc). 2010 Dec;75(12):1428-34.
56. Flavin D. Reversing splenomegalies in Epstein Barr Virus infected children: Mechanisms of toxicity in viral diseases. JOM, 2006 Second Qaurter;21(2):95-101.
57. Tomasin R, Cintra Gomes-Marcondes MC. Oral administration of Aloe vera and honey reduces walker tumour growth by decreasing cell proliferation and increasing apoptosis in tumour tissue. Phytother Res.
2010 Sep 13. [Epub ahead of print]
58. See: http://doctorapsley.com/RadiationTherapy.aspx
Other Compelling References of Interest:
_________________________________________________
The confusion and/or obfuscation lies in how one defines what "success is" when treating cancer. For example:
Is it all about reducing mortality rates from cancer? No.
Is it all about increasing Quality of Life for cancer patients in those conventionally treated verses properly matched patients who opted for no treatment at all? No.
Is it all about extending overall survival for cancer patients in those conventionally treated verses properly matched patients who received no treatment at all? No again.
Is it about preventing cancer patients from filing from bankruptcy, due to the astronomical, budget-busting and ever escalating fees demanded by the cancer-control-industry? Absolutely not!
What the current statistics suggest are improved successes with conventional treatments that are of such as nature they either:
(A) Cannot be confirmed, or
(B) Have nothing to do with the most important measures as listed above.
Alternatively, cancer trials designed to document patient survival are invited to use more accurate statistical analysis such as The Hardin Jones-Pauling Biostatistical Theory of Survival Analysis for Clinical Trials of Cohorts of Cancer Patients. See: http://orthomolecular.org/library/jom/1998/articles/1998-v13n03-p141.shtml
For now see below:
__________________________________________________________
Chemotherapy Failure Rate
Morgan G, Wardy R, Bartonz M. Overview: The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies. Clinical Oncology, 2004;16: 549-60.
*Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW; Department of Medical Oncology, St Vincent’s Hospital, Sydney, NSW; Collaboration for Cancer Outcomes Research and Evaluation, Liverpool Health Service, Sydney, NSW, Australia
Abstract
Aims: The debate on the funding and availability of cytotoxic drugs raises questions about the contribution of curative or adjuvant cytotoxic chemotherapy to survival in adult cancer patients. Materials and methods: We undertook a literature search for randomised clinical trials reporting a 5-year survival benefit attributable solely to cytotoxic chemotherapy in adult malignancies. The total number of newly diagnosed cancer patients for 22 major adult malignancies was determined from cancer registry data in Australia and from the Surveillance Epidemiology and End Results data in the USA for 1998. For each malignancy, the absolute number to benefit was the product of (a) the total number of persons with that malignancy; (b) the proportion or subgroup(s) of that malignancy showing a benefit; and (c) the percentage increase in 5-year survival due solely to cytotoxic chemotherapy. The overall contribution was the sum total of the absolute numbers showing a 5-year survival benefit expressed as a percentage of the total number for the 22 malignancies. Results: The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA. Conclusion: As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required.
doi:10.1016/j.clon.2004.06.007
__________________________________________________________
Abel U. Chemotherapy of advanced epithelial cancer--a critical review. Biomed Pharmacother. 1992;46(10):439-52.
Tumorzentrum Heidelburg/Mannheim, Germany.
Abstract
This article is a short version of a report which presents a comprehensive analysis of clinical trials and publications examining the value of cytotoxic chemotherapy in the treatment of advanced epithelial cancer. As a result of the analysis and the comments received from hundreds of oncologists in reply to a request for information, the following facts can be noted. Apart from lung cancer, in particular small-cell lung cancer, there is no direct evidence that chemotherapy prolongs survival in patients with advanced carcinoma. Except for ovarian cancer, available indirect evidence rather supports the absence of a positive effect. In treatment of lung cancer and ovarian cancer, the therapeutical benefit is at best rather small, and a less aggressive treatment seems to be at least as effective as the usual one. It is possible that certain sub-groups of patients benefit from the treatment, yet so far the available results do not allow a sufficiently precise definition of these groups. Many oncologists take it for granted that response to therapy prolongs survival, an opinion which is based on a fallacy and which is not supported by clinical studies. To date, it is unclear whether the treated patients, as a whole, benefit from chemotherapy as to their quality of life. For most cancer sites, urgently required types of studies such as randomized de-escalations of dose or comparisons of immediate versus deferred chemotherapy are still lacking. With few exceptions, there is no good scientific basis for the application of chemotherapy in symptom-free patients with advanced epithelial malignancy.
PMID: 1339108 [PubMed - indexed for MEDLINE]
__________________________________________________________
Radiation Therapy Failure Rate and Dangers
As long ago as 1968, at a prestigious national convention on cancer, William Powers, M.D., Director of the Division of Radiation Therapy at the Washington University School of Medicine, Phillip Rubin, M.D., Chief of the Division of Radiotherapy at the University of Rochester Medical School, and Vera Peters, M.D., of the Princess Margaret Hospital in Toronto, Canada. Dr. Powers reported:
"Although preoperative and postoperative radiation therapy have been used extensively and for decades, it is still not possible to prove unequivocal clinical benefit from this combined treatment.... Even if the rate of cure does improve with a combination of radiation and therapy, it is necessary to establish the cost in increased morbidity which may occur in patients without favorable response to the additional therapy."1
"From the data available it would seem that the use of post-operative irradiation has provided no discernible advantage to patients so treated in terms of increasing the proportion who were free of disease for as long as five years. (And in conclusion)… The clinical evidence and statistical data in numerous reviews are cited to illustrate that no increase in survival has been achieved by the addition of irradiation."2
References for Radiation Therapy quotes above:
1. Preoperative and Postoperative Radiation Therapy for Cancer, speech delivered to the Sixth National Cancer Conference, sponsored by the American Cancer Society
and the National Cancer Institute, Denver, Colorado, Sept. 18—20, 1968.
2. Fisher B, et. al., "Postoperative Radiotherapy in the Treatment of Breast Cancer; Results of the NSAPP Clinical Trial," Annals of Surgery, 1970 Oct;172(4):711-32.
For 2010 just as it was in 1970, the risks verses benefits of radiation therapy remain in doubt and unsubstantiated. If results from cancer treatments of any kind were rated in mortality rates, this would be ideal. For determining REAL benefits from conventional treatments, you have to compare conventional treatments to appropriately matched cases that did not receive conventional treatments of any kind. This takes out much of the bias so rampant in reporting favorable results with chemotherapy, radiation therapy or a combination thereof. Unfortunately, the medical community is not undertaking such studies.
Lastly, radiation therapy commonly causes life-threatening or maiming after affects months or years down the road. An exhaustive study was undertaken by John W. Gofman, M.D., Ph.D., Professor Emeritus University of California, Berkeley, and he concludes that: “Medical radiation is a highly important cause (probably the principal cause) of cancer mortality in the United States during the Twentieth Century. Medical radiation means, primarily, exposure by xrays (including fluoroscopy and CT scans)... Medical radiation, received even at very low and moderate doses, is an important cause of death from Ischemic Heart Disease; the probable mechanism is radiation-induction of mutations in the coronary arteries, resulting in dysfunctional clones (mini-tumors) of smooth muscle cells.”
See: Risk-Benefit Report on Radiation Therapy.pdf.
__________________________________________________________
Surgery Failure Rates
Hardin B. Jones, Ph.D., former professor of medical physics and physiology at the University of California at Berkeley delivered this now famous report of findings to the American Cancer Society:
"In regard to surgery, no relationship between intensity of surgical treatment and duration of survival has been found in verified malignancies. On the contrary, simple excision of cancers has produced essentially the same survival as radical excision and dissection of the lymphatic drainage... Although there is a dearth of untreated cases for statistical comparison with the treated, it is surprising that the death risks of the two groups remain so similar. In the comparisons it has been assumed that the treated and untreated cases are independent of each other. In fact, that assumption is incorrect. Initially, all cases are untreated. With the passage of time, some receive treatment, and the likelihood of treatment increases with the length of time since origin of the disease. Thus, those cases in which the neoplastic process progresses slowly [and thus automatically favors a long-term survival] are more likely to become "treated" cases. For the same reason, however, those individuals are likely to enjoy longer survival, whether treated or not. Life tables truly representative of untreated cancer patients must be adjusted for the fact that the inherently longer-lived cases are more likely to be transferred to the "treated" category than to remain in the "untreated until death."1
In essence, the overall survival of untreated cancer cases after appropriate adjustments (disgorging the spin) results in better overall survival than those of treated cases!
Lastly, Johnstone confesses that:
"A patient who has clinically detectable distant metastases when first seen has virtually a hopeless prognosis, as do patients who were apparently free of distant metastases at that time but who subsequently return with distant metastases."2
References for Radiation Therapy quotes above: 1. Hardin B. Jones, Ph.D. "A Report on Cancer," paper delivered to the ACS’s 11th Annual Science Writers Conference, New Orleans, Mar. 7, 1969.
2. Johnstone FRC. Results of treatment of carcinoma of the breast based on pathological staging, Gynecology & Obstetrics 1972;134:211.
Were the truth to be known today via honest accounting methods, would the results be any different for 2000-2010 as they were for 1970? Well, let's see now below...
__________________________________________________________
Conventional Treatments Failure Rates - All
Bailar JC 3rd, Gornik HL. Cancer undefeated. N Engl J Med. 1997 May 29;336(22):1569-74.
Department of Health Studies, University of Chicago, IL 60637-1470, USA.
Also see Comment in:
N Engl J Med. 1997 Sep 25;337(13):931-4; discussion 937-8.
N Engl J Med. 1997 Sep 25;337(13):935; author reply 937-8.
N Engl J Med. 1997 Sep 25;337(13):936.
N Engl J Med. 1997 Sep 25;337(13):936-7; author reply 937-8.
N Engl J Med. 1997 Sep 25;337(13):936; author reply 937-8.
N Engl J Med. 1997 Sep 25;337(13):936; author reply 937-8.
N Engl J Med. 1997 Sep 25;337(13):937; author reply 937-8.
N Engl J Med. 1997 Sep 25;337(13):937; author reply 937-8.
N Engl J Med. 1997 Sep 25;337(13):937; author reply 937-8.
Abstract
BACKGROUND: Despite decades of basic and clinical research and trials of promising new therapies, cancer remains a major cause of morbidity and mortality. We assessed overall progress against cancer in the United States from 1970 through 1994 by analyzing changes in age-adjusted mortality rates. METHODS: We obtained from the National Center for Health Statistics data on all deaths from cancer and from cancer at specific sites, as well as on deaths due to cancer according to age, race, and sex, for the years 1970 through 1994. We computed age-specific mortality rates and adjusted them to the age distribution of the U.S. population in 1990. RESULTS: Age-adjusted mortality due to cancer in 1994 (200.9 per 100,000 population) was 6.0 percent higher than the rate in 1970 (189.6 per 100,000). After decades of steady increases, the age-adjusted mortality due to all malignant neoplasms plateaued, then decreased by 1.0 percent from 1991 to 1994. The decline in mortality due to cancer was greatest among black males and among persons under 55 years of age. Mortality among white males 55 or older has also declined recently. These trends reflect a combination of changes in death rates from specific types of cancer, with important declines due to reduced cigarette smoking and improved screening and a mixture of increases and decreases in the incidence of types of cancer not closely related to tobacco use. CONCLUSIONS: The war against cancer is far from over. Observed changes in mortality due to cancer primarily reflect changing incidence or early detection. The effect of new treatments for cancer on mortality has been largely disappointing. The most promising approach to the control of cancer is a national commitment to prevention, with a concomitant rebalancing of the focus and funding of research.
PMID: 9164814 [PubMed - indexed for MEDLINE]
__________________________________________________________
Epstein SS, et al. The crises in U.S. and international cancer policy. Int J Health Serv. 2002;32(4):669-707.
University of Illinois School of Public Health, Chicago 60612, USA. epstein@uic.edu
Abstract
The incidence of cancer in the United States and other major industrialized nations has escalated to epidemic proportions over recent decades, and greater increases are expected. While smoking is the single largest cause of cancer, the incidence of childhood cancers and a wide range of predominantly non-smoking-related cancers in men and women has increased greatly. This modern epidemic does not reflect lack of resources of the U.S. cancer establishment, the National Cancer Institute and American Cancer Society; the NCI budget has increased 20-fold since passage of the 1971 National Cancer Act, while funding for research and public information on primary prevention remains minimal. The cancer establishment bears major responsibility for the cancer epidemic, due to its overwhelming fixation on damage control--screening, diagnosis, treatment, and related molecular research--and indifference to preventing a wide range of avoidable causes of cancer, other than faulty lifestyle, particularly smoking. This mindset is based on a discredited 1981 report by a prominent pro-industry epidemiologist, guesstimating that environmental and occupational exposures were responsible for only 5 percent of cancer mortality, even though a prior chemical industry report admitted that 20 percent was occupational in origin. This report still dominates public policy, despite overwhelming contrary scientific evidence on avoidable causes of cancer from involuntary exposures to a wide range of environmental carcinogens. Since 1998, the ACS has been planning to gain control of national cancer policy, now under federal authority. These plans, developed behind closed doors and under conditions of nontransparency, with recent well-intentioned but mistaken bipartisan Congressional support, pose a major and poorly reversible threat to cancer prevention and to winning the losing war against cancer.
PMID: 12456121 [PubMed - indexed for MEDLINE]
__________________________________________________________
Howe GK, Clapp RW. Are we winning or losing the war on cancer? Deciphering the propaganda of NCI's 33-year war. New Solut. 2004;14(2):109-24.
BU School of Public Health, Boston, MA 02118, USA.
Abstract
The National Cancer Institute (NCI) and collaborating agencies have proclaimed great progress in the U.S. "war on cancer," while at the same time presenting more reasons for concern than celebration. We reviewed various documents and data files and found that incidence and mortality rates for all cancer sites combined remain higher than they were when the "war on cancer" was declared in 1971, despite very recent, modest decreases. The burden of the disease has risen from three million to nearly ten million people. Black Americans, men of all races, and other segments of the population disproportionately bear the burden of cancer. We also looked at data for malignant breast cancer and found that incidence rates increased 36% from 1973 to 2000, while mortality for all population groups combined declined slightly. Breast cancer mortality is 34% higher among black women than among white women, even though white women are generally more likely to get the disease. The $50 billion spent on the "war on cancer" over the last 33 years has yielded few gains. The NCI's resources must be refocused on preventing cancers we know how to prevent.
PMID: 17208743 [PubMed]
__________________________________________________________
Death Rates from Conventional Treatments
The National Confidential Enquiry into Patient Outcome and Death (NCEPOD) - 2008
Systemic Anti-Cancer Therapy: For better, for worse? A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy
D Mort MRCGP FRCR, Clinical Co-ordinator
M Lansdown MCh FRCS. Clinical Co-ordinator
N Smith PhD, Clinical Researcher
K Protopapa BSc (Hons), Researcher
M Mason PhD, Chief Executive
Summary
A recent comprehensive study on systemic anti-cancer therapy (SACT) concluded that 40% of cancer patients receiving chemotherapy suffer potentially lethal fatal side effects from the treatment. In addition, chemotherapy was determined “inappropriate” for nearly 20% of cancer cases which had been prescribed conventional chemotherapy. This report also cited an alarming finding that for cancer patients dying within the first 30 days of receiving SACT, 27% were due to the treatment itself, and not the cancer.
See: NCEPOD-SACT Report.pdf
__________________________________________________________
Non-Treated End-Stage Cancer Patients May Live Longer with Higher Quality of Life (QoL) than Those Conventionally Treated.
Temel JS, et al., Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer, N Engl J Med 2010 Aug 19; 363:733-742.
Background
Patients with metastatic non–small-cell lung cancer have a substantial symptom burden and may receive aggressive care at the end of life. We examined the effect of introducing palliative care (management of symptoms, psychosocial support, and assistance with decision making,) early after diagnosis on patient-reported outcomes and end-of-life care among ambulatory patients with newly diagnosed disease.
Methods
We randomly assigned patients with newly diagnosed metastatic non–small-cell lung cancer to receive either early palliative care integrated with standard oncologic care or standard oncologic care alone. Quality of life and mood were assessed at baseline and at 12 weeks with the use of the Functional Assessment of Cancer Therapy–Lung (FACT-L) scale and the Hospital Anxiety and Depression Scale, respectively. The primary outcome was the change in the quality of life at 12 weeks. Data on end-of-life care were collected from electronic medical records.
Results
Of the 151 patients who underwent randomization, 27 died by 12 weeks and 107 (86% of the remaining patients) completed assessments. Patients assigned to early palliative care had a better quality of life than did patients assigned to standard care (mean score on the FACT-L scale [in which scores range from 0 to 136, with higher scores indicating better quality of life], 98.0 vs. 91.5; P=0.03). In addition, fewer patients in the palliative care group than in the standard care group had depressive symptoms (16% vs. 38%, P=0.01). Despite the fact that fewer patients in the early palliative care group than in the standard care group received aggressive end-of-life care (33% vs. 54%, P=0.05), median survival was longer among patients receiving early palliative care (11.6 months vs. 8.9 months, P=0.02).
Conclusions
Among patients with metastatic non–small-cell lung cancer, early palliative care led to significant improvements in both quality of life and mood. As compared with patients receiving standard care, patients receiving early palliative care had less aggressive care at the end of life but longer survival. (Funded by an American Society of Clinical Oncology Career Development Award and philanthropic gifts; ClinicalTrials.gov number, NCT01038271.)
See: http://www.nejm.org/doi/full/10.1056/NEJMoa1000678#articleTop
__________________________________________________________
Note: The Failure of conventional oncology is especially acute for epithelial cancers, which comprise approximately 80% of all cancer incidence. The following successes apply only to the remaining 20% of cancer incidence...
Apparent Successes for Conventional Treatments - All
Acute Lymphocystic Leukemia 60% Success Rate
Burkitt's Lymphoma (Stage I) 90%
Childhood Lymphomas 75%
Childhood Sarcomas 70% - 90%
Choriocarcinoma (Low-Risk cases) 90%
Diffuse Histiocytic Lymphoma 70%
Hodgkin's Lymphoma (Stages III-IV) 60%
Nodular Mixed Lymphoma 75%
Skin Cancer (Basal Cell and Squamous Cell) (Stages I-II) +90%
Small Cell Lung Cancer (Minor improvement) (A few extra months of life)
Testicular Carcinoma (Stages II-III) 70% - 90%
References for Radiation Therapy quotes above: 1. Cecil's Textbook of Medicine - 1988.
With today's improved earlier detection diagnostic technologies, the above reported success rates may be slightly improved from the 1988 levels.
The use of the term "apparent" above is for three reasons:
A. The above reported rates of success have not been confirmed via: The Hardin Jones-Pauling Biostatistical Theory of Survival Analysis for Clinical Trials of Cohorts
of Cancer Patients.
B. These improvements do not include the greater risk of developing lethal complications, ischemic heart disease, arthritis, intestinal disorders, immune deficiency
disorders, reproductive disorders, blood disorders or greater risk (~60% or more depending upon conventional treatment intensity) for treatment-induced future
cancers such as lymphoma and leukemia.
C. No comparison has been made between eclectic, extremely low toxic approaches for treating the same cancers, such as, BEC-5 for treating skin cancers, or John Holt's
method of treating the above solid tumor cases (Choriocarcinoma, Small Cell Lung Cancer, Testicular Carcinoma and Childhood Sarcomas), or Insulin Potentiated
Therapy (IPT) for treating the above blood-borne and lymphatic-borne cancers.*
__________________________________________________________
*See:
http://www.vanuatumedical.com/dr_cham;
http://www.radiowaveclinic.com/; and
http://www.euro-med.us/ respectively.